US Stock MarketDetailed Quotes

MGX Metagenomi Technologies, LLC

Watchlist
  • 2.150
  • +0.040+1.90%
Close Nov 6 16:00 ET
  • 2.110
  • -0.040-1.86%
Post 16:40 ET
80.47MMarket Cap-1073P/E (TTM)

About Metagenomi Technologies, LLC Company

Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit-ing toolbox, ther-a-peu-tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.

Company Profile

SymbolMGX
Company NameMetagenomi Technologies, LLC
Listing DateFeb 9, 2024
Issue Price15.00
Founded2016
CEOMr. Brian C. Thomas, PhD
MarketNASDAQ
Employees236
Fiscal Year Ends12-31
Address5959 Horton Street,7th floor
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-871-4880

Company Executives

  • Name
  • Position
  • Salary
  • Brian C. Thomas, PhD
  • Chief Executive Officer and Chairman of the Board
  • 7.52M
  • Pamela Wapnick, M.B.A.
  • Chief Financial Officer and Chief Accounting Officer
  • --
  • Dr. Sarah B. Noonberg, M.D.,PhD
  • Chief Medical Officer
  • 2.04M
  • Dr. Luis G. Borges, PhD
  • Chief Scientific Officer
  • --
  • Simon Harnest, M. Sc.
  • Chief Investment Officer and Senior Vice President of Strategy
  • --
  • Dr. Jian Irish, M.B.A.,PhD
  • President, Chief Operating Officer and Director
  • 2.27M
  • Matthew L. Wein, J.D.
  • Vice President, Corporate Legal and Compliance and Corporate Secretary
  • --
  • Alan Brooks, PhD
  • Senior Vice President of Preclinical
  • --
  • Christopher T. Brown, PhD
  • Vice President of Discovery
  • --
  • Michael Conway, C.P.A.,M.B.A.
  • Vice President of Finance
  • --
  • Dr. Simren Delaney, L.L.M.,PhD
  • Vice President, Intellectual Property and Legal Operations
  • --
  • Sebastian Bernales, PhD
  • Independent Director
  • --
  • Dr. Willard H. Dere, M.D.
  • Independent Director
  • 49.20K
  • Dr. Juergen Eckhardt, M.B.A.,M.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data